{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:38:56Z","timestamp":1789133936635,"version":"build-2803163510"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0230368","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T17:28:50Z","timestamp":1585157330000},"page":"e0230368","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study"],"prefix":"10.1371","volume":"15","author":[{"given":"Win Min","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalita","family":"Wattanachanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanakorn","family":"Apornpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jureeporn","family":"Jantrapakde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3222-9611","authenticated-orcid":true,"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipat","family":"Teeratakulpisarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanate","family":"Jadwattanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawatchai","family":"Chaiwatanarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patinut","family":"Buranasupkajorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshmie","family":"Ramautarsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nittaya","family":"Phanuphak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarat","family":"Sunthornyothin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiat","family":"Ruxrungtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praphan","family":"Phanuphak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"TNT 003.1 study team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,3,25]]},"reference":[{"issue":"17","key":"pone.0230368.ref001","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"TT Brown","year":"2006","journal-title":"Aids"},{"issue":"9","key":"pone.0230368.ref002","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system","volume":"93","author":"VA Triant","year":"2008","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"12","key":"pone.0230368.ref003","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1097\/QAD.0b013e328361d241","article-title":"Incident fractures in HIV-infected individuals: a systematic review and meta-analysis","volume":"27","author":"S Shiau","year":"2013","journal-title":"Aids"},{"issue":"6","key":"pone.0230368.ref004","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jbmr.1874","article-title":"HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: a population-based cohort study","volume":"28","author":"R Guerri-Fernandez","year":"2013","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"2","key":"pone.0230368.ref005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11908-014-0393-1","article-title":"Bones, Fractures, Antiretroviral Therapy and HIV","volume":"16","author":"LA Battalora","year":"2014","journal-title":"Curr Infect Dis Rep"},{"issue":"4","key":"pone.0230368.ref006","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/infdis\/jiw204","article-title":"Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals","volume":"214","author":"PM Grant","year":"2016","journal-title":"J Infect Dis"},{"issue":"4","key":"pone.0230368.ref007","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/infdis\/jiu499","article-title":"Low bone mineral density in patients with well-suppressed HIV infection: association with body weight, smoking, and prior advanced HIV disease","volume":"211","author":"KW Kooij","year":"2015","journal-title":"J Infect Dis"},{"issue":"1","key":"pone.0230368.ref008","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/498511","article-title":"Bone disease and HIV infection","volume":"42","author":"V Amorosa","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pone.0230368.ref009","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/501015","article-title":"HIV infection and bone mineral density in middle-aged women","volume":"42","author":"JH Arnsten","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pone.0230368.ref010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jbmr.2051","article-title":"Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW)","volume":"29","author":"JE Compston","year":"2014","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"8","key":"pone.0230368.ref011","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/656412","article-title":"Bone disease in HIV infection: a practical review and recommendations for HIV care providers","volume":"51","author":"GA McComsey","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"10","key":"pone.0230368.ref012","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/cid\/cit538","article-title":"Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation","volume":"57","author":"PM Grant","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pone.0230368.ref013","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/367569","article-title":"Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals","volume":"36","author":"K Mondy","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"12","key":"pone.0230368.ref014","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/QAD.0000000000000320","article-title":"Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study","volume":"28","author":"CO Hileman","year":"2014","journal-title":"Aids"},{"issue":"2","key":"pone.0230368.ref015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00774-016-0749-8","article-title":"Bone metabolism dysfunction mediated by the increase of proinflammatory cytokines in chronic HIV infection","volume":"35","author":"EG de Menezes","year":"2017","journal-title":"Journal of bone and mineral metabolism"},{"issue":"3","key":"pone.0230368.ref016","doi-asserted-by":"crossref","first-page":"e0193679","DOI":"10.1371\/journal.pone.0193679","article-title":"Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection","volume":"13","author":"MC Vlot","year":"2018","journal-title":"PLoS One"},{"key":"pone.0230368.ref017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09540121.2019.1622631","article-title":"Antiretroviral-naive HIV-infected patients had lower bone formation markers than HIV-uninfected adults","author":"L Wattanachanya","year":"2019","journal-title":"AIDS care"},{"issue":"8","key":"pone.0230368.ref018","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/656417","article-title":"Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study","volume":"51","author":"HJ Stellbrink","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pone.0230368.ref019","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/QAD.0b013e328328f789","article-title":"Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients","volume":"23","author":"C Duvivier","year":"2009","journal-title":"Aids"},{"issue":"3","key":"pone.0230368.ref020","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/COH.0000000000000248","article-title":"Tenofovir and bone health","volume":"11","author":"PM Grant","year":"2016","journal-title":"Current opinion in HIV and AIDS"},{"key":"pone.0230368.ref021","unstructured":"World Health Organization. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: World Health Organization,; 2018."},{"issue":"5","key":"pone.0230368.ref022","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","article-title":"Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen","volume":"51","author":"TT Brown","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"pone.0230368.ref023","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/infdis\/jiw204","article-title":"Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals","volume":"214","author":"PM Grant","year":"2016","journal-title":"The Journal of Infectious Diseases"},{"issue":"7929","key":"pone.0230368.ref024","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for derivation of renal threshold phosphate concentration","volume":"2","author":"RJ Walton","year":"1975","journal-title":"Lancet"},{"issue":"9","key":"pone.0230368.ref025","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1093\/cid\/ciu617","article-title":"Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America","volume":"59","author":"GM Lucas","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"8","key":"pone.0230368.ref026","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"JA Kanis","year":"1994","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"12","key":"pone.0230368.ref027","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/infdis\/jir188","article-title":"Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202","volume":"203","author":"GA McComsey","year":"2011","journal-title":"J Infect Dis"},{"issue":"9987","key":"pone.0230368.ref028","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(15)60616-X","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials","volume":"385","author":"PE Sax","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"pone.0230368.ref029","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"JE Gallant","year":"2004","journal-title":"Jama"},{"issue":"11","key":"pone.0230368.ref030","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/S2352-3018(15)00181-2","article-title":"Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001\/ANRS143 randomised trial","volume":"2","author":"JI Bernardino","year":"2015","journal-title":"Lancet HIV"},{"issue":"4","key":"pone.0230368.ref031","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/QAI.0000000000000618","article-title":"Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study","volume":"69","author":"A Mills","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"13","key":"pone.0230368.ref032","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/QAD.0b013e328361d25d","article-title":"Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density","volume":"27","author":"KM Erlandson","year":"2013","journal-title":"Aids"},{"key":"pone.0230368.ref033","unstructured":"Todd T Brown MTY, Samir Gupta, Christine Katlama, Adriano Lazzarin, Kathy Melbourne, Calvin Cohen, et al. Switching from TDF To TAF in HIV-Infected Adults With Low BMD: A Pooled Analysis. Conference on Retroviruses and Opportunistic Infections (CROI),; February 13\u201316, 2017; Seattle, WA2017."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T17:29:23Z","timestamp":1585157363000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230368"}},"subtitle":[],"editor":[{"given":"Robert","family":"G\u00fcerri-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,25]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0230368","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,25]]}}}